Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1996;27:1231-1235

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Kooten, F.
Right arrow Articles by Koudstaal, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Kooten, F.
Right arrow Articles by Koudstaal, P. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH

(Stroke. 1996;27:1231-1235.)
© 1996 American Heart Association, Inc.


Articles

Lipoprotein(a) in Patients With Acute Cerebral Ischemia

Fop van Kooten, MD; Johannes van Krimpen, MD; Diederik W.J. Dippel, MD; Nicoline Hoogerbrugge, MD Peter J. Koudstaal, MD

the Departments of Neurology (F. van Kooten, J. van Krimpen, D.W.J.D, P.J.K.) and Internal Medicine III (N.H.), University Hospital Rotterdam Dijkzigt, the Netherlands.

Correspondence to Fop van Kooten, MD, Department of Neurology, University Hospital Rotterdam Dijkzigt, 40 Dr Molewaterplein, 3015 GD Rotterdam, Netherlands. E-mail vanKooten@neuro.fgg.eur.nl.

Background and Purpose In several cross-sectional studies, a high serum lipoprotein(a) [Lp(a)] level was found to be an independent risk factor for cerebral infarction. In a recent prospective study, however, no association was found between Lp(a) levels at baseline and future risk of stroke. Whether Lp(a) is a prognostic factor in a high-risk population of patients with acute ischemic stroke remains unclear.

Methods We assessed Lp(a) level on admission to study its relationship with cardiovascular risk profile, stroke severity, and prognosis in 151 consecutive patients with acute cerebral ischemia. The mean follow-up period was 2.5±1.2 years. Lp(a) was measured by means of a solid-phase two-site immunoradiometric assay.

Results Increased Lp(a) levels were found in 53 (35%) of the patients with cerebral ischemia. Median (5th and 95th percentile) values of Lp(a) were 191 (12 and 1539) mg/L and 197 (10 and 1255) mg/L for patients with transient ischemic attack and patients with ischemic stroke, respectively. No relationship was found between Lp(a) levels and stroke severity (P=.68) or the occurrence of vascular events during follow-up (P log rank=0.81).

Conclusions We conclude that Lp(a) is increased in about one third of patients with acute cerebral ischemia, but it does not appear to be associated with the cardiovascular risk profile, stroke characteristics, or the prognosis of such patients.


Key Words: cerebral ischemia • lipoproteins • prognosis




This article has been cited by other articles:


Home page
StrokeHome page
B. Smolders, R. Lemmens, and V. Thijs
Lipoprotein (a) and Stroke: A Meta-Analysis of Observational Studies
Stroke, June 1, 2007; 38(6): 1959 - 1966.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Zambrelli, E. Emanuele, S. Marcheselli, L. Montagna, D. Geroldi, and G. Micieli
Apo(a) size in ischemic stroke: Relation with subtype and severity on hospital admission
Neurology, April 26, 2005; 64(8): 1366 - 1370.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K.-L. Chien, F.-C. Sung, H.-C. Hsu, T.-C. Su, R.-S. Lin, and Y.-T. Lee
Apolipoprotein A-I and B and Stroke Events in a Community-Based Cohort in Taiwan: Report of the Chin-Shan Community Cardiovascular Study
Stroke, January 1, 2002; 33(1): 39 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
H. J Milionis, A. F Winder, and D. P Mikhailidis
Lipoprotein (a) and stroke
J. Clin. Pathol., July 1, 2000; 53(7): 487 - 496.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. J. Harjai
Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen
Ann Intern Med, September 7, 1999; 131(5): 376 - 386.
[Abstract] [Full Text] [PDF]